scispace - formally typeset
B

Banafsheh Golestan

Researcher at Tehran University of Medical Sciences

Publications -  44
Citations -  896

Banafsheh Golestan is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Socioeconomic status & Vitamin B12. The author has an hindex of 17, co-authored 44 publications receiving 805 citations. Previous affiliations of Banafsheh Golestan include University of Tehran.

Papers
More filters
Journal ArticleDOI

Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

TL;DR: Omega-3 fatty acids may be an efficient neuroprotective agent for prophylaxis against PIPN and patients with breast cancer have a longer disease free survival rate with the aid of therapeutical agents.
Journal ArticleDOI

Decomposing socioeconomic inequality in self-rated health in Tehran

TL;DR: Age, marital status, level of education and household economic status were significantly associated with SRH in both the crude and adjusted analyses, and sub-optimal SRH was more in lower than in higher economic status.
Journal Article

Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women.

TL;DR: In this paper, a double-blinded, placebo-controlled, randomized trial included 74 middle-aged overweight women who were randomly assigned to receive either 250 mg magnesium as magnesium oxide or placebo daily for 8 weeks.
Journal ArticleDOI

Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: A comprehensive gene analysis

TL;DR: The 986S, 990G and 1011Q alleles were associated with a recurrent calcium kidney stone-forming state and nine polymorphisms were detected in CASR exons, all in the coding region of exon 7, which was associated with hypercalcaemia.
Journal ArticleDOI

An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.

TL;DR: Serum testosterone was related to higher urinary excretion of uric acid in ASF patients and to higher renal stone risk by increasing the urinary excrete of calcium and phosphorus in the control group.